Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Parallax Volatility Advisers Invests Heavily in Biotech Giant Amgen

Guavy AI Editorial Team
Instruments
AMGN
Share

Parallax Volatility Advisers L.P., a financial investment company, has made a new $1.94 million investment in Amgen Inc., a leading biotechnology company.

The purchase was disclosed in Parallax's most recent 13F filing with the Securities and Exchange Commission (SEC).

Parallax purchased 5,354 shares of Amgen stock, valued at approximately $1,939,000. This marks a significant investment for Parallax in the biotech industry.

More on Stocks

Stocks just now

Magic Apron Rolls Out Nationwide to All U.S. Home Depot Stores

Stocks 1m ago

Walmart Shareholders See Big Moves from Top Institutional Investors

Stocks 1m ago

Amazon to Close Mechanical Turk Amid Market Expectations for Continued Growth

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy